U.S. Physical Therapy (USPH) Competitors

$103.19
-0.20 (-0.19%)
(As of 01:21 PM ET)

USPH vs. PRVA, LFST, PNTG, INNV, TALK, DVAX, INMD, EYE, PTGX, and EWTX

Should you be buying U.S. Physical Therapy stock or one of its competitors? The main competitors of U.S. Physical Therapy include Privia Health Group (PRVA), LifeStance Health Group (LFST), The Pennant Group (PNTG), InnovAge (INNV), Talkspace (TALK), Dynavax Technologies (DVAX), InMode (INMD), National Vision (EYE), Protagonist Therapeutics (PTGX), and Edgewise Therapeutics (EWTX). These companies are all part of the "medical" sector.

U.S. Physical Therapy vs.

Privia Health Group (NASDAQ:PRVA) and U.S. Physical Therapy (NYSE:USPH) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, community ranking, analyst recommendations and valuation.

U.S. Physical Therapy has a net margin of 4.67% compared to U.S. Physical Therapy's net margin of 1.39%. Privia Health Group's return on equity of 8.52% beat U.S. Physical Therapy's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group1.39% 3.97% 2.43%
U.S. Physical Therapy 4.67%8.52%3.92%

Privia Health Group currently has a consensus price target of $27.92, indicating a potential upside of 48.49%. U.S. Physical Therapy has a consensus price target of $125.67, indicating a potential upside of 21.41%. Given U.S. Physical Therapy's higher probable upside, equities research analysts clearly believe Privia Health Group is more favorable than U.S. Physical Therapy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
0 Sell rating(s)
2 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.82
U.S. Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Privia Health Group has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, U.S. Physical Therapy has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.

In the previous week, Privia Health Group had 5 more articles in the media than U.S. Physical Therapy. MarketBeat recorded 8 mentions for Privia Health Group and 3 mentions for U.S. Physical Therapy. U.S. Physical Therapy's average media sentiment score of 0.77 beat Privia Health Group's score of 0.67 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
U.S. Physical Therapy
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

U.S. Physical Therapy has lower revenue, but higher earnings than Privia Health Group. U.S. Physical Therapy is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$1.66B1.35$23.08M$0.1998.95
U.S. Physical Therapy$604.80M2.58$28.24M$1.3576.67

94.5% of Privia Health Group shares are owned by institutional investors. 14.2% of Privia Health Group shares are owned by company insiders. Comparatively, 1.8% of U.S. Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

U.S. Physical Therapy received 194 more outperform votes than Privia Health Group when rated by MarketBeat users. However, 72.22% of users gave Privia Health Group an outperform vote while only 56.04% of users gave U.S. Physical Therapy an outperform vote.

CompanyUnderperformOutperform
Privia Health GroupOutperform Votes
52
72.22%
Underperform Votes
20
27.78%
U.S. Physical TherapyOutperform Votes
246
56.04%
Underperform Votes
193
43.96%

Summary

Privia Health Group and U.S. Physical Therapy tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

USPH vs. The Competition

MetricU.S. Physical TherapyHealth services IndustryMedical SectorNYSE Exchange
Market Cap$1.56B$824.22M$4.84B$17.45B
Dividend Yield1.78%1.78%5.51%3.59%
P/E Ratio76.6735.41240.8925.24
Price / Sales2.582.442,419.7510.80
Price / Cash21.2519.2732.1714.95
Price / Book3.252.244.685.01
Net Income$28.24M-$15.00M$102.52M$963.51M
7 Day Performance5.43%9.55%0.41%2.52%
1 Month Performance-6.46%-7.38%-5.79%-1.85%
1 Year Performance-2.73%6.88%10.14%90.34%

U.S. Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
4.5788 of 5 stars
$17.69
-3.6%
$28.18
+59.3%
-28.3%$2.10B$1.66B93.111,102Analyst Report
LFST
LifeStance Health Group
1.444 of 5 stars
$5.62
-3.9%
$8.60
+53.0%
-23.9%$2.14B$1.06B-11.029,325Analyst Report
PNTG
The Pennant Group
2.2517 of 5 stars
$20.01
+0.5%
$18.75
-6.3%
+67.6%$608.10M$544.89M45.485,791News Coverage
INNV
InnovAge
0.8347 of 5 stars
$4.09
-1.2%
$6.50
+58.9%
N/A$555.83M$720.80M-16.362,100Gap Down
TALK
Talkspace
0.4554 of 5 stars
$3.03
-5.3%
$3.00
-1.0%
+292.5%$511.77M$150.04M-25.25472
DVAX
Dynavax Technologies
4.5116 of 5 stars
$11.49
-1.7%
$25.00
+117.6%
+6.7%$1.50B$232.28M-191.47408Positive News
INMD
InMode
3.4765 of 5 stars
$17.62
-0.4%
$32.80
+86.2%
-53.6%$1.48B$492.05M7.66581Positive News
EYE
National Vision
3.5541 of 5 stars
$18.88
-1.8%
$23.86
+26.4%
-8.1%$1.48B$2.13B-22.2113,998Positive News
PTGX
Protagonist Therapeutics
1.7531 of 5 stars
$26.11
-1.8%
$36.00
+37.9%
+11.8%$1.52B$60M-17.52112Positive News
EWTX
Edgewise Therapeutics
1.5299 of 5 stars
$16.63
+0.9%
$33.00
+98.4%
+105.4%$1.55BN/A-10.5388Analyst Report
News Coverage

Related Companies and Tools

This page (NYSE:USPH) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners